Cargando…

Association of Cirrhosis and Cardiomyopathy

INTRODUCTION: We investigated association of pro-BNP, troponin-I, electrocardiography (ECG) and echocardiography (ECHO) during diagnosis and identification of cirrhotic cardiomyopathy in cirrhotic patients. MATERIALS AND METHODS: Patients were divided into three groups as; compensated cirrhotic pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sezgin, Burcu, Cindoglu, Cigdem, Uyanikoglu, Ahmet, Yenice, Necati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969323/
https://www.ncbi.nlm.nih.gov/pubmed/31988863
http://dx.doi.org/10.5005/jp-journals-10018-1291
_version_ 1783489305575948288
author Sezgin, Burcu
Cindoglu, Cigdem
Uyanikoglu, Ahmet
Yenice, Necati
author_facet Sezgin, Burcu
Cindoglu, Cigdem
Uyanikoglu, Ahmet
Yenice, Necati
author_sort Sezgin, Burcu
collection PubMed
description INTRODUCTION: We investigated association of pro-BNP, troponin-I, electrocardiography (ECG) and echocardiography (ECHO) during diagnosis and identification of cirrhotic cardiomyopathy in cirrhotic patients. MATERIALS AND METHODS: Patients were divided into three groups as; compensated cirrhotic patients (group 1, n= 30), decompensated cirrhotic (group 2, n = 30) and control group (group 3, n = 30). ECHO, and ECG were performed, and troponin-I and levels of pro-BNP were analyzed. RESULTS: Average age of group 1 was 46.36 ± 16 years (range 19-86), 60% were female; group 2 was 57.03 ± 13.54 years (range 22-89), 56% female; and group 3 was 49.13 ± 0.95 years (range 18-80), 56% female. A significant increase in QTc was detected in compensated cirrhotic patients compared to the control group (p <0.05). Pro-BNP levels were significantly higher (p <0.05) in the compensated cirrhotic group compared to the control group. The levels of pro-BNP were also significantly higher in the decompensated cirrhotic group compared compensated cirrhosis group and control group (p <0.001). CONCLUSION: The increase of pro-BNP levels with severity of the disease in cirrhotic patients and the prolongation of QTc interval supports an association between these factors with cardiomyopathy. HOW TO CITE THIS ARTICLE: Sezgin B, Cindoglu C, et al. Association of Cirrhosis and Cardiomyopathy. Euroasian J Hepatogastroenterol 2019;9(1):23-26.
format Online
Article
Text
id pubmed-6969323
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-69693232020-01-27 Association of Cirrhosis and Cardiomyopathy Sezgin, Burcu Cindoglu, Cigdem Uyanikoglu, Ahmet Yenice, Necati Euroasian J Hepatogastroenterol Research Article INTRODUCTION: We investigated association of pro-BNP, troponin-I, electrocardiography (ECG) and echocardiography (ECHO) during diagnosis and identification of cirrhotic cardiomyopathy in cirrhotic patients. MATERIALS AND METHODS: Patients were divided into three groups as; compensated cirrhotic patients (group 1, n= 30), decompensated cirrhotic (group 2, n = 30) and control group (group 3, n = 30). ECHO, and ECG were performed, and troponin-I and levels of pro-BNP were analyzed. RESULTS: Average age of group 1 was 46.36 ± 16 years (range 19-86), 60% were female; group 2 was 57.03 ± 13.54 years (range 22-89), 56% female; and group 3 was 49.13 ± 0.95 years (range 18-80), 56% female. A significant increase in QTc was detected in compensated cirrhotic patients compared to the control group (p <0.05). Pro-BNP levels were significantly higher (p <0.05) in the compensated cirrhotic group compared to the control group. The levels of pro-BNP were also significantly higher in the decompensated cirrhotic group compared compensated cirrhosis group and control group (p <0.001). CONCLUSION: The increase of pro-BNP levels with severity of the disease in cirrhotic patients and the prolongation of QTc interval supports an association between these factors with cardiomyopathy. HOW TO CITE THIS ARTICLE: Sezgin B, Cindoglu C, et al. Association of Cirrhosis and Cardiomyopathy. Euroasian J Hepatogastroenterol 2019;9(1):23-26. Jaypee Brothers Medical Publishers 2019 /pmc/articles/PMC6969323/ /pubmed/31988863 http://dx.doi.org/10.5005/jp-journals-10018-1291 Text en Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd. © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sezgin, Burcu
Cindoglu, Cigdem
Uyanikoglu, Ahmet
Yenice, Necati
Association of Cirrhosis and Cardiomyopathy
title Association of Cirrhosis and Cardiomyopathy
title_full Association of Cirrhosis and Cardiomyopathy
title_fullStr Association of Cirrhosis and Cardiomyopathy
title_full_unstemmed Association of Cirrhosis and Cardiomyopathy
title_short Association of Cirrhosis and Cardiomyopathy
title_sort association of cirrhosis and cardiomyopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969323/
https://www.ncbi.nlm.nih.gov/pubmed/31988863
http://dx.doi.org/10.5005/jp-journals-10018-1291
work_keys_str_mv AT sezginburcu associationofcirrhosisandcardiomyopathy
AT cindoglucigdem associationofcirrhosisandcardiomyopathy
AT uyanikogluahmet associationofcirrhosisandcardiomyopathy
AT yenicenecati associationofcirrhosisandcardiomyopathy